Parenteral Drugs (India) reports standalone net loss of Rs 17.30 crore in the September 2014 quarter

Sales decline 10.16% to Rs 47.46 crore

Net Loss of Parenteral Drugs (India) reported to Rs 17.30 crore in the quarter ended September 2014 as against net loss of Rs 14.14 crore during the previous quarter ended September 2013. Sales declined 10.16% to Rs 47.46 crore in the quarter ended September 2014 as against Rs 52.83 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales47.4652.83 -10 OPM %5.737.34 -PBDT-11.96-9.38 -28 PBT-16.38-13.74 -19 NP-17.30-14.14 -22

Powered by Capital Market - Live News